| __timestamp | ImmunityBio, Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 1595000 | 382096000000 |
| Thursday, January 1, 2015 | 11434000 | 345927000000 |
| Friday, January 1, 2016 | 26546000 | 312303000000 |
| Sunday, January 1, 2017 | 39778000 | 325441000000 |
| Monday, January 1, 2018 | 53418000 | 368298000000 |
| Tuesday, January 1, 2019 | 111997000 | 492381000000 |
| Wednesday, January 1, 2020 | 139507000 | 455833000000 |
| Friday, January 1, 2021 | 195958000 | 526087000000 |
| Saturday, January 1, 2022 | 248149000 | 633325000000 |
| Sunday, January 1, 2023 | 232366000 | 729924000000 |
| Monday, January 1, 2024 | 729924000000 |
Unlocking the unknown
In the ever-evolving world of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Takeda Pharmaceutical Company Limited and ImmunityBio, Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Takeda's R&D expenses have surged by nearly 91%, reaching a peak in 2023. This reflects their strategic focus on expanding their research capabilities and developing new therapies. In contrast, ImmunityBio, Inc. has shown a remarkable growth trajectory, with R&D spending increasing by over 14,500% from 2014 to 2023. This exponential rise underscores their aggressive push towards innovation, albeit from a smaller base. While Takeda's spending dwarfs that of ImmunityBio, the latter's rapid growth highlights its potential to disrupt the industry. As we look to the future, these trends offer a glimpse into the dynamic landscape of pharmaceutical innovation.
Comparing Innovation Spending: Johnson & Johnson and ImmunityBio, Inc.
Analyzing R&D Budgets: Zoetis Inc. vs Takeda Pharmaceutical Company Limited
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs United Therapeutics Corporation
R&D Insights: How Takeda Pharmaceutical Company Limited and Exelixis, Inc. Allocate Funds
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs Iovance Biotherapeutics, Inc.
Takeda Pharmaceutical Company Limited vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Takeda Pharmaceutical Company Limited or Taro Pharmaceutical Industries Ltd.: Who Invests More in Innovation?
Research and Development Investment: Takeda Pharmaceutical Company Limited vs BioCryst Pharmaceuticals, Inc.
R&D Insights: How Halozyme Therapeutics, Inc. and ImmunityBio, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Amneal Pharmaceuticals, Inc. and ImmunityBio, Inc.
Perrigo Company plc or ImmunityBio, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for ImmunityBio, Inc. and Celldex Therapeutics, Inc.